This article provides a comprehensive analysis of current strategies and emerging technologies for mitigating teratoma formation risk in human pluripotent stem cell (hPSC)-derived therapies.
This article provides a comprehensive overview of the latest strategies in tissue engineering that combine stem cells with advanced biomaterial scaffolds.
Single-cell RNA sequencing (scRNA-seq) is revolutionizing the characterization of patient-derived stem cell lines by providing unprecedented resolution of cellular heterogeneity, dynamic transitions, and drug response mechanisms.
This article provides a comprehensive guide to Good Manufacturing Practice (GMP) compliance for researchers and drug development professionals navigating the complex transition from laboratory research to clinical manufacturing of patient-specific...
The transition of personalized stem cell therapies from laboratory research to clinical application is contingent on overcoming significant manufacturing challenges.
This article provides a comprehensive analysis of stem cell-derived exosomes as a next-generation, cell-free platform for personalized regenerative medicine.
This article provides a comprehensive overview of autologous mesenchymal stem cell (MSC) transplantation, a promising personalized therapeutic approach.
This article provides a comprehensive guide for researchers and drug development professionals on the methods for creating 3D organoid disease models from patient stem cells.
The generation of cardiomyocytes from human induced pluripotent stem cells (hiPSCs) has revolutionized cardiovascular research, offering an unprecedented platform for patient-specific disease modeling and drug discovery.
This article provides a comprehensive guide for researchers and drug development professionals on the latest CRISPR-based strategies for correcting disease-causing mutations in stem cells.